Hisamitsu Pharmaceutical CoFSE:4530 89 Median PS Value is 円6,723.00 as of Jun. 26, 2026, which is 100% below its 10-year median of 0.70. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07. Among 544 Drug Manufacturers companies, Hisamitsu Pharmaceutical Co ranks better than 72.98% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Median PS Value or its related term are showing as below:
FSE:4530'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.59 Med: 0.7 Max: 0.75
Current: 0.59
During the past 13 years, the highest Price to Median PS Value of Hisamitsu Pharmaceutical Co was 0.75. The lowest was 0.59. And the median was 0.70.
FSE:4530's Price-to-Median-PS-Value is ranked better than 72.98% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.83
vs FSE:4530: 0.59
Hisamitsu Pharmaceutical Co (FSE:4530) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Hisamitsu Pharmaceutical Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3975.00
/
6,723.00
=
0.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co Median PS Value Related Terms
Hisamitsu Pharmaceutical Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hisamitsu Pharmaceutical Co Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.9732.
Hisamitsu Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2261.238.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co (FSE:4530) has a Median PS Value of 円6,723.00 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Hisamitsu Pharmaceutical Co and its competitors. This is 960329% above median its historical median of 0.70. Over the past decade, Hisamitsu Pharmaceutical Co's Median PS Value has ranged from 0.59 to 0.75. According to the industry distribution chart, Hisamitsu Pharmaceutical Co ranks #147 out of 544 companies in the Drug Manufacturers industry, placing it in the top 27%.
Is Hisamitsu Pharmaceutical Co's Median PS Value too high?
Hisamitsu Pharmaceutical Co's current Median PS Value of 円6,723.00 is 960329% above median its 10-year median of 0.70. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 0.75. Based on the distribution chart, Hisamitsu Pharmaceutical Co ranks #147 out of 544 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Median PS Value compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hisamitsu Pharmaceutical Co ranks #147 out of 544 companies for Median PS Value. This puts Hisamitsu Pharmaceutical Co in the upper half of its industry. The industry median Median PS Value is 0.83. Historically, Hisamitsu Pharmaceutical Co's own Median PS Value has ranged from 0.59 to 0.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.83, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Hisamitsu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hisamitsu Pharmaceutical Co's current Median PS Value is 円6,723.00, which is 960329% above median its own 10-year median of 0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current Median PS Value of 円6,723.00. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current Median PS Value is 円6,723.00, which is 960329% above median its 10-year median of 0.70. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current Median PS Value is 円6,723.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.
Key valuation signals for FSE:4530:
Median PS Value: 円6,723.00 (960329% above median its 10-year median of 0.70)
GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score
Get the complete analysis for FSE:4530
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSE:4530 has been successfully added to your 
